Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
批准号:
10527264
负责人:
Wiljeana Glover
金额:
$29.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-15 至 2027-06-30
关键词:
Active LearningAddressBasic ScienceBiological SciencesBusinessesCommunitiesCoupledCustomDecision MakingDevelopmentDevicesDiagnostic EquipmentDrug AddictionEconomic DevelopmentEducationEducational CurriculumElectronic MailEmerging TechnologiesEntrepreneurshipEnvironmentFacultyFutureGoalsGrowthHealthHealthcareImmersionIndividualIndustryIntellectual PropertyMarketingMechanicsMobile Health ApplicationNational Institute of Drug AbuseNeurosciencesNewsletterOrganizational CultureOutcomeParticipantPatient RecruitmentsPersonal SatisfactionPharmaceutical PreparationsPublic HealthResearchResearch PersonnelRewardsRoleScientistStructureSubstance Use DisorderTechniquesTechnologyTherapeuticThinkingTrainingUncertaintyUnited StatesUnited States National Institutes of HealthWorkbasecollegecommercializationcommunity buildingcurriculum developmentexperienceimprovedinnovationinterestnew technologyorganizational structureoutreachproduct developmentprogramsrecruitskill acquisitionsubstance use treatmentsymposiumtool
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Babson Life Sciences Entrepreneurial Product Development Immersion for New
Technologies and Solutions (Babson L-SPRINT) Program
Commercialized innovations and new ventures that address certain conditions, including
ventures that address the causes, consequences, and treatment of substance use disorders
(SUDs) to improve individual and public health, are still underrepresented amongst recent
startups. Commercialization and technology-based start-ups can be challenging in an academic
environment due to varying reward structures, organizational structures and organizational
cultures. Many promising scientists are reluctant to pursue intellectual property (IP) protection
and investigate commercialization opportunities, even for unique research findings, due to a lack
of understanding of the mechanics towards productizing and commercialization.
To address these misperceptions and challenges while amplifying the potential impact that
academic scientists can make to address SUDs, the Babson Life Sciences Entrepreneurial
Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT)
Program will reach scientists interested in product development and commercialization as well as
to train participants in entrepreneurial thinking that can also increase decision making, improve
their organizations and labs from within, especially since product development in the biomedical
industry is highly uncertain. The Babson L-SPRINT Program includes two aims:
Aim 1: Curriculum Development--The Babson L-SPRINT program will develop a specialized
curriculum highlighting Babson’s signature Entrepreneurial Thought & Action ® offering coupled
with customized healthcare and biomedical entrepreneurship content on addressing market
segmentation and uncertainty, commercializing emerging technologies, scaling for growth, and
biomedical community experiences. The program will use live cases, panels, and other
experiential learning techniques.
Aim 2: Courses for Skills Development--We will also develop a recruitment and outreach
strategy using an innovative omnichannel approach including direct marketing utilizing email,
relevant conferences, and via NIH NIDA newsletters and other media as available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
-
批准号:10678869
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2022
-
负责人:Wiljeana Glover
-
依托单位:
海外基金